Top Stock Movers Today — September 4, 2026: Why IMRN, CDTG, GRNQ, NRSN & GRI Surged
Immuron spiked 60% on a US launch announcement. Here's a full breakdown of today's five biggest stock gainers at the September 4, 2026 close.
IMRN — Immuron Ltd (+60.4%)
Immuron closed at $1.78, up 60.4% on the day, with volume of 595,079,836 shares — more than 19 times its 20-day average of roughly 29.8 million shares. A move of that magnitude on that kind of relative volume is a clear signal that something fundamental triggered the buying.
Why it moved: A September 4 headline from Yahoo Finance confirmed the catalyst — Immuron announced the US launch of PROIBS®, its product targeting the irritable bowel syndrome market. A US commercial launch is one of the most anticipated milestones for a small healthcare company, and the market responded emphatically.
From a technical standpoint, IMRN opened with a gap of +63.1% — a gap meaning the stock's opening price jumped sharply above the prior day's close with no trading in between. RSI (Relative Strength Index, a momentum gauge where readings above 70 signal overbought conditions) hit 78, confirming the strength but also flagging that the stock is statistically stretched. The RS rating of 84 reflects solid recent relative performance, and the technical rank sits at 97. Conviction score is 57/100. The MA stack (the alignment of multiple moving averages) is bullish. The trend-template score of 4 out of 7 indicates a partial but not complete Minervini-style uptrend alignment.
Short interest is low at just 39,935 shares, so this wasn't a short squeeze — the squeeze score is 39/100. The float (the portion of shares available for public trading) is 97.8%, meaning nearly all shares were in play. The near-tripling of price from a standing start on a single news event is a classic high-volatility, catalyst-driven pop. These moves often retrace sharply once the news-day buying exhausts itself — IMRN is still 24.3% below its 52-week high, underlining that today's gain, while enormous, didn't break new annual ground.
IMRN was also featured in this morning's premarket recap, where it was already moving ahead of the open.
CDTG — CDT Environmental Technology Investment Holdings Ltd (+44.5%)
CDT Environmental Technology closed at $1.30, up 44.5%, on volume of 49,924,379 shares — nearly 5× its 20-day average of about 10.1 million. The market cap sits at just $17.6 million, placing CDTG firmly in micro-cap territory where even modest order flow can move a stock dramatically.
Why it moved: There are no headlines or SEC filings that explain today's surge. A Schedule 13G (a passive-stake disclosure filed when an investor accumulates 5% or more without intent to influence control) was filed on August 21, but that's too stale to be the direct trigger. With no identifiable catalyst in the data, this move appears to be momentum- and technically-driven.
The float is 93.9%, so the shares outstanding are widely available, and short interest is a negligible 73,076 shares with just 0.1 days to cover (days to cover measures how many days of average trading volume it would take short sellers to buy back all borrowed shares — a low reading means a squeeze is unlikely). The squeeze score of 27/100 backs that up. What's notable technically is the ADX (Average Directional Index, a trend-strength indicator) reading of 47, which signals a strong directional trend in progress even as the MA stack (moving averages) remains mixed. RSI at 49 is neutral, meaning the stock isn't stretched despite the gain. CDTG sits 81.9% below its 52-week high, a reminder that today's move came off a deeply depressed base. The smart-money score is 30/100 with a largest disclosed stake of 5.1%. Micro-cap names with no clear catalyst and a single-day volume spike carry outsized reversal risk.
GRNQ — Greenpro Capital Corp. (+29.5%)
Greenpro Capital closed at $18.52, up 29.5%, on volume of 12,122,582 shares — roughly 19× its 20-day average of about 630,000 shares. The market cap reached $335.6 million. GRNQ is a technology-sector company, and the volume surge here is exceptional.
Why it moved: No headlines are on file, and no SEC filings within the last few days provide a specific catalyst. However, the technical picture for GRNQ is arguably the cleanest of today's five movers. GRNQ closed at a 52-week high, with an RSI of 64 (elevated but not overbought), an ADX of 26 (moderate trend strength), a bullish MA stack, a technical rank of 99, an RS rating of 99, and a conviction score of 96/100 — the highest on today's list. Its grade is A+ and it scores 7/7 on the Minervini trend template, meaning it satisfies every criterion of that institutional momentum framework (strong price vs. moving averages, rising averages, high relative strength).
CEO Lee Chong Kuang disclosed a $50,000 open-market purchase of 28,949 shares back in May — a modest but directionally positive insider signal. Short interest is tiny at just 1,543 shares, so no squeeze dynamic is at play (squeeze score 37/100). The free float is 55.2%, somewhat tighter than the other movers today, meaning fewer shares are available for trading, which can amplify price moves when volume spikes. Without a disclosed catalyst, the move looks technically and momentum-driven — but the setup quality is genuinely high. Hitting a fresh 52-week high on 19× normal volume is the kind of action institutional momentum strategies specifically seek. That said, stocks extended this far without a news anchor can reverse just as fast.
NRSN — NeuroSense Therapeutics Ltd. (+28.3%)
NeuroSense Therapeutics closed at $0.52, up 28.3%, on volume of 9,178,177 shares — about 13× its 20-day average of roughly 702,000 shares. With a market cap of only $16.8 million, NRSN is one of the smallest names on today's list, and it trades below $1 — a zone where volatility is structurally elevated.
Why it moved: No news headlines or recent filings explain the move. The most recent SEC filing is a 6-K (a foreign private issuer's report of significant events) from August 27, which is too old to be today's trigger. With no identifiable catalyst, this appears to be a momentum-driven pop in a thinly traded micro-cap. Notably, a short-sale restriction (SSR) is active on NRSN — SSR kicks in automatically when a stock falls 10% or more from the prior day's close, and it limits certain short-selling tactics for the remainder of that day and the next. An SSR being active today implies NRSN had a rough prior session, making today's bounce even more striking.
Short interest stands at 489,130 shares with 2.3 days to cover and a squeeze score of 38/100 — moderate but not alarming. The free float is 65.3%. The MA stack is bearish, the technical rank is just 27, and the conviction score is a low 24/100 (grade D). NRSN's RS rating of 4 means it has dramatically underperformed the broader market over the past year — it still sits 62.1% below its 52-week high. CEO Ben-Noon Alon bought 250,000 shares ($200,000) in June, a more meaningful insider commitment, but that's a months-old signal. The weak technical profile combined with the absence of a catalyst makes this one of the higher-risk moves on today's list.
GRI — GRI Bio, Inc. (+25.3%)
GRI Bio closed at $2.87, up 25.3%, on volume of 5,865,341 shares — approximately 7× its 20-day average of about 800,000 shares. The market cap is just $6.3 million, making GRI the smallest company on today's list by a wide margin.
Why it moved: No news headlines are on file, and the most recent SEC filings — a 10-Q quarterly report and a Schedule 13G/A (an amended passive-stake disclosure) — both date to August 13–14, well before today's session. With no identifiable catalyst, the move appears momentum- and technically-driven, potentially amplified by the stock's extremely small market cap and relatively light float.
Despite the absence of a news catalyst, GRI's technical profile is notably solid. RSI hit 77 (approaching overbought territory), ADX is 42 (indicating a strong trend), and the conviction score is 76/100 (grade A) with a trend-template score of 6/7. RS rating of 91 reflects meaningful recent outperformance. The gap on the day was just +1.3%, meaning most of the day's gain came from intraday buying rather than a pre-open jump. The free float is 97.9%, so nearly all shares were in circulation. Short interest is modest at 127,075 shares with only 0.2 days to cover, and the squeeze score is 44/100 — the highest of today's movers, though still not in classic squeeze territory. A $6.3 million market cap means the stock can be moved by relatively small dollar amounts. At 48.3% below its 52-week high, GRI has a long technical road to recovery even after today's gain.
The bottom line
Today's five biggest gainers — IMRN, CDTG, GRNQ, NRSN, and GRI — illustrate the full spectrum of what drives big single-day moves: a concrete product-launch catalyst (IMRN), strong technical momentum at 52-week highs (GRNQ), an SSR-triggered bounce in a beaten-down micro-cap (NRSN), and unexplained volume surges in names with tiny market caps (CDTG, GRI).
A few honest reminders before you act on any of this:
- Chasing extended gainers is high-risk. Stocks that surge 25–60% in a single session frequently give back a substantial portion of those gains in the days that follow, especially when the move is volume- or momentum-driven without a durable catalyst.
- Patterns and squeeze setups fail. Even high-conviction technical reads — RSI, ADX, MA stacks, squeeze scores — are probabilistic, not guaranteed. A great-looking chart can roll over quickly.
- Small-cap and micro-cap stocks carry structural risks. Wide bid-ask spreads, thin liquidity, and sensitivity to small order flows make these names especially dangerous to trade without a clear plan.
- Manage your risk. Know your stop before you enter, size positions appropriately, and never risk more than you can afford to lose.
StockSetups scans the full ~12,300-stock US universe after every close, detecting chart patterns, confirmed candlestick signals, and momentum setups across all four trading lanes — so you can see which names are setting up, breaking out, or retesting before the next session opens. For this morning's premarket view, see the September 4 premarket recap, and for yesterday's close movers, check the September 3 after-close recap.
This article is educational only and is not financial advice or a recommendation to buy or sell any security. Always do your own research.
Frequently asked questions
Why is IMRN up today?
Immuron (IMRN) surged 60.4% on September 4, 2026 after announcing the US launch of its PROIBS® product, a significant commercial milestone that drove volume to nearly 20× the 20-day average.
Why is GRNQ up today?
Greenpro Capital (GRNQ) closed up 29.5% at a 52-week high on 19× normal volume. No specific news catalyst was on file; the move appears technically driven, supported by top-tier momentum scores including a 96/100 conviction score and perfect 7/7 trend-template score.
What is a low-float short squeeze?
A low-float stock has few shares available for public trading. When heavily shorted — meaning many traders have borrowed and sold shares betting on a decline — a sudden price rise forces those short sellers to buy shares to cover their losses, driving the price even higher. This feedback loop is called a short squeeze. Low float amplifies the effect because there are fewer shares available to absorb the buying demand.
What does SSR (short-sale restriction) mean for NRSN?
SSR — short-sale restriction — is triggered automatically by regulators when a stock drops 10% or more from the prior close. It restricts certain types of short-selling for the rest of that day and the following trading day. For NRSN, it signals the stock had a significant prior-session decline, which context its sharp bounce on September 4.
Are these stocks good buys after such big single-day gains?
Not necessarily. Stocks that gain 25–60% in a single session are statistically prone to sharp reversals, especially when moves are news- or momentum-driven rather than backed by sustained fundamental improvement. These recaps are educational — always do your own research and manage risk carefully before making any trading decisions.
Produced with AI assistance and published under the StockSetups editorial guidelines.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy